Ani Pharmaceuticals reported $-4447000 in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 3179M 2413M
Aerie Pharmaceuticals AERI:US $ -39.69M 1M
Ani Pharmaceuticals ANIP:US $ -4.45M 9.66M
Aurora Cannabis Inc ACB:CN -11884000 116.24M
Canopy Growth Corp WEED:CN C$ -11058000 403.48M
Depomed DEPO:US $ 3.74M 17.91M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Emergent Biosolutions EBS:US $ -32.7M 37.3M
Endo International Ordinary Shares ENDP:US $ -77.21M 61.71M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Hikma Pharmaceutical HIK:LN 248M 29M
Knight Therapeutics Inc GUD:CN C$ -8586000 37.59M
Lannett LCI:US $ -22.34M 155.54M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Novartis NVS:US $ 2758M 138M
Omeros OMER:US $ -22703000 5.89M
Perrigo Ordinary Shares PRGO:US $ -58.9M 1.2M
Sun Pharmaceuticals SUNP:IN IR 20470.1M 6028.4M
Teva Pharmaceutical TEVA:IT 290M 83M
Teva Pharmaceutical Industries TEVA:US $ 290M 83M